Development of the antimicrobial effectiveness test as USP Chapter 〈51〉

PDA Journal of Pharmaceutical Science and Technology

Volumn 56, Issue 6, 2002, Pages 300-311

  Sutton, Scott V W ^a   Porter, David ^b  

^a ALCON RESEARCH LTD   (United States)

^b UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PRESERVATIVE;

ANTIMICROBIAL ACTIVITY; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; DRUG SCREENING; ESCHERICHIA COLI; GOOD MANUFACTURING PRACTICE; GROWTH INHIBITION; LABORATORY TEST; MICROBIAL GROWTH; MICROORGANISM; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; SCREENING TEST; STAPHYLOCOCCUS AUREUS; STORAGE;

BACTERIA; DRUG COMPOUNDING; DRUG CONTAMINATION; FUNGI; MICROBIAL SENSITIVITY TESTS; PHARMACOPOEIAS; PRESERVATIVES, PHARMACEUTICAL; UNITED STATES;

EID: 0036860106     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. th Revision, (1970), Rockville, MD., p. 845.
2. Leitz, M., (1972), "Critique of U.S.P. microbiological test," Bull Parenter Drug Assoc., 26 (5), 212-216.
3. Rdzok, E. J, W. E. Grundy, F. J. Kirchmeyer, and J. C. Sylvester, (1955), "Determining the efficacy of preservatives in pharmaceutical products," J Amer Pharm. Assoc., Sci. Ed., 44, 613-1616.
4. Yablonski, J. I., (1972), "Fundamental concepts of preservation," Bull Parenter Drug Assoc., 26 (5), 220-227.
5. The United States Pharmacopeial Convention, Inc., (effective January 1, 1990), "Ranitidine oral solution," First Supplement to The United States Pharmacopeia 22/National Formulary 17, Rockville, MD., p 2167.
6. Cooper, M. S., (1994), "Some issues associated with international harmonization of the preservative effectiveness test," Pharmacopeial Forum, 20 (6), 8589-8592.
7. Leavitt, J. M., I. J. Naidorf, and P. Shugaesky, (1955), "The undetected anaerobe in endodontics; a sensitive medium for detection of both aerobes and anaerobes," The NY J Dentist, 25, 377-382.
8. Kellog, D. S., (1972), "Preservative testing as applied to quality control systems," Bull Parenter Drug Assoc., 26 (5), 216-220.
9. th Revision, Rockville, MD., p. 587.
10. th Revision, Rockville, MD.
11. Tan, T. G. and R.C. Wilson, (1980), "The efficacy of antimicrobial agents in Parenteral Products assessed by the USP XIX method compared to the USP XVIII method," J. Parenteral Drug Assoc., 34 (6), 431-435.
12. th Revision, Rockville, MD., p. 873.
13. st Revision Rockville, MD. p. 1151.
14. nd Revision, Rockville, MD, p. 1478.
15. Pharmacopeial Forum, 8 (3), 2058, May-June 1982.
16. Orth, D. S., (1979), "Linear regression method for rapid determination of cosmetic preservative efficacy," J. Soc. Cosmet. Chem., 30, 321-332.
17. Orth, D. S., C. M. Lutes, S. R. Milstein, and J. J. Allinger, (1987), "Determination of shampoo preservative stability and apparent activation energies by the linear regression method of preservative efficacy testing," J. Soc. Cosmet. Chem., 38, 307-319.
18. Orth, D. S., C. M. Lutes, and D. K. Smith, (1989), "Effect of culture conditions and method of inoculum preparation on the kinetics of bacterial death during preservative efficacy testing," J. Soc. Cosmet. Chem., 40, 193-203.
19. Orth, D. S., (1980), "Establishing cosmetic preservative efficacy by use of d-values," J. Soc. Cosmet. Chem., 31, 165-172.
20. Davies, D. J. et al. (1976), "Design of a standard protocol for the challenge testing of antimicrobial preservative solutions," J. Pharm Pharmacol Suppl., 28, 49.
21. Sutton, S. V. W., R. J. Franco, D. A. Porter, M. F. Mowrey-McKee, S. C. Busschaert, J. Hamberger, and D. W. Proud, (1991), "D-value determinations are an inappropriate measure of disinfecting activity of common contact lens disinfecting solutions," Appl. Environ. Microbiol., 57, 2021-2026.
22. Houlsby, R. D., (1980), "An alternate approach for preservative testing of ophthalmic multiple-dose products," J. Parenter Drug Assoc., 34 (4), 272-276.
23. Brannan, D. K. and J. C. Dille, (1990), "Type of closure prevents microbial contamination of cosmetics during consumer use," Appl Environ Microbiol., 56 (5), 1476-1479.
24. Abshire, R. L. and B. A. Schelech, (1982), "A method for evaluating the effectiveness of preservative systems in water-imiscible ointments," J. Parent. Sci. Technol., 36, 216-221.
25. Cooper, M. S., (1989), "Preservative efficacy: Compendial and regulatory issues," J. Parent. Sci. Technol., 43, 187-189.
26. Pharmacopeial Forum, 18 (2), 3048, Mar-Apr 1992.
27. Pharmacopeial Forum, 21 (4), 1040, July-Aug 1995.
28. Pharmacopeial Forum, 22 (6), 3212, Nov-Dec 1996.
29. Pfaller, M. A., L. Burmeister, M. S. Barlett, and M. G. Rinaldi, (1988), "Multicenter evaluation of four methods of yeast inoculum preparation," J. Clin Microbiol., 26 (4), 1437-1441.
30. Muth, H. and W. Casey, (2000), "The effects of antimicrobial preservatives on organisms derived from fresh versus frozen cultures," Pharmacopeial Forum, 26 (2), 519.
31. Pharmacopeial Forum, 23 (2), 3806, Mar-Apr 1997.
32. The United States Pharmacopeial Convention, Inc., (effective May 15, 1998), Eighth Supplement to The United States Pharmacopeia 23/National Formulary 18, Rockville, MD, p. 1681.
33. The United States Pharmacopeial Convention, Inc., (1990), "Proceedings from the November 1990 Open Conference on Microbiology and Sterilization Issues," USP, Rockville, MD.
34. Cooper, M. S., (1994), "Some issues associated with international harmonization of the preservative effectiveness test," Pharmacopeial Forum, 20 (6), 8589-8592.
35. Dabbah, R. and J. E. Knapp, (1997), "Harmonization of microbiological methods - A status report," Pharmacopeial Forum, 23 (6), 5334.
36. Pharmacopeial Forum, 25 (1), 7513, Jan-Feb 1999.
37. Wallhäusser, K.-H., (1973), "Antimicrobial preservatives in Europe: Experience with preservatives used in pharmaceuticals and cosmetics," Develop. Biol. Standard, 24, 9-28.
38. PharmEuropa, 5 (4), 355-358, 1993.
39. Hodges, N. A., S. P. Denyer, G. W. Hanlon, and J. P. Reynolds, (1996), "Preservative efficacy tests in formulated nasal products: Reproducibility and factors affecting preservative efficacy," J. Pharm Pharmacol., 48, 1237-1242.
40. PharmEuropa, 6 (4), 387-388, 1994.
41. PharmEuropa, Special Issue, October 1996, p. 89.
42. Gilbert, P., M. R. W. Brown, and J. W. Costerton, (1987), "Inocula for antimicrobial sensitivity testing: A critical review," J. Antimicrob Chemother., 20, 147-154.
43. Cooper, M. S., (1998), The Microbiological Update, 16(9).
44. Cooper, M. S., (1999), The Microbiological Update, 17(7).
45. Davison, A. L., W. L. Hooper, D. F. Spooner, J. A. Farwell, and R. Baird, (1991), "The validity of the criteria of pharmacopeial preservative efficacy tests - A pilot study," Pharm J., 246, 555-557.
46. Spooner, D. F. and A. L. Davison, (1993), "The validity of the criteria for pharmacopeial antimicrobial preservative efficacy tests," Pharm J., 251, 602-605.
47. Matthews, B. R., (1993), "Preservative efficacy testing," Reg Affairs J., pp. 455-461.
48. Farrington, J. K., E. L. Martz, S. J. Wells, C. C. Ennis, J. Holder, J. W. Levchuk, K. E. Avis, P. S. Hoffman, A. D. Hitchins, and J. M. Madden, (1994), "Ability of laboratory methods to predict in-use efficacy of antimicrobial preservatives in experimental cosmetic, " Appl Environ Microbiol., 60 (12), 4553-4558.
49. Livingstone, D. J., G. W. Hanlon, and S. Dyke, (1998), "Evaluation of an extended period of use for preserved eye drops in hospital practice," Br. J. Ophthalmol., 82, 473-475.
50. Kim, G. E., K. D. Fern, and J. A. Perrigin, (1997), "Sterility of ophthalmic drugs dispensed from spray bottles," Optometry and Vision Sci., 74 (10), 865-867.
51. PharmEuropa, 3 (2), 241-244, 1991.
52. PharmEuropa, 13 (3), 597-599, 2001.
53. Pharmacopeial Forum, 24 (3), 6269, May-June 1998.
54. Pharmacopeial Forum, 27 (1), 2034, Jan-Feb 2001.
55. Sutton, S. V. W., B. Matthews, and D. Dunn, (1998), "In-use shelf-life testing - What data are required and when?" Regulatory Affairs Journal, 9, 728-733.
56. CPMP/QWP/2934/99 "Note for guidance on in-use stability testing of human medicinal products." Effective September 2001.
57. CPMP/QWP/159/96, corr "Note for guidance on maximum shelf-life of sterile products for human use after first opening or following reconstitution," effective July 1998.
58. CPMP/CVMP/QWP/115/95, "Note for guidance on inclusion of antioxidants and antimicrobial preservatives in medicinal products," effective January 1998.
59. EMEA/CVMP/127/95. "Note for guidance: In-use stability testing of veterinary medicinal products," effective September 1996.
60. EMEA/CVMP/424/01, "Note for guidance on in-use stability testing of veterinary medicinal products (excluding immunological veterinary medicinal products)," effective September 2002.